Literature DB >> 12769303

Aetiological agents, clinical features and outcome of septicaemia in infants in Ibadan.

O O Ayoola1, A A Adeyemo, K Osinusi.   

Abstract

UNLABELLED: The present study sought to determine the prevalence, clinical features and bacterial aetiological agents of septicaemia in post-neonatal infants (age 1-12 months) presenting with fever at the University College Hospital, Ibadan, Nigeria. STUDY
SETTING: It was carried out at the Otunba Tunwase Children Emergency Ward (OTCHEW) (a 40 bedded ward) of the Department of Paediatrics, University College Hospital, Ibadan, Nigeria. PATIENTS: All postneonatal infants aged 1-12 months presenting with fever and who had not had antibiotic treatment in the week prior to presentation during the period June to November 1998 were enrolled in the study. Each child had a full clinical evaluation followed by a blood culture.
RESULTS: The infants comprised 56 (54.9%) males and 46 (45.1%) females. The mean age was 5.6 (SD 0.3) months. The prevalence of septicaemia in the infants studied was 38.2%. Clinical features associated with increased risk of septicaemia among these infants were age < or = 6 months, restlessness and a total white cell count > or = 15000/mm3. The organisms isolated in the infants studied were Escherichia coli (35.9% of positive cultures). Staphylococcus aureus (33.3%), Klebsiella species (10.3%), Streptococcus species (7.7%), Proteus species (5.1%), Pseudomonas species (5.1%) and Salmonella species (2.6%). Mortality was significantly higher in patients with septicaemia (25.7% compared with those without septicaemia (7.9%).
CONCLUSIONS: Thirty eight percent of febrile infants presenting in this study had positive bacteria blood cultures, the most common organisms being Escherichia coli and Staphylococcus aureus. Few clinical features distinguished febrile infants with septicaemia from those without. It is recommended that febrile infants in our setting with clinical features associated with increased risk of septicaemia should be treated emprically with antibiotics since the probability of having septicaemia is significant.

Entities:  

Mesh:

Year:  2003        PMID: 12769303     DOI: 10.4314/wajm.v22i1.27975

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  6 in total

Review 1.  Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis.

Authors:  Elizabeth A Reddy; Andrea V Shaw; John A Crump
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

2.  Using hospital-based studies of community-onset bloodstream infections to make inferences about typhoid fever incidence.

Authors:  Christian S Marchello; Ariella P Dale; Sruti Pisharody; John A Crump
Journal:  Trop Med Int Health       Date:  2019-11-19       Impact factor: 2.622

3.  A Systematic Review and Meta-analysis of the Prevalence of Community-Onset Bloodstream Infections among Hospitalized Patients in Africa and Asia.

Authors:  Christian S Marchello; Ariella P Dale; Sruti Pisharody; Matthew P Rubach; John A Crump
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

4.  A systematic review and meta-analysis of the aetiological agents of non-malarial febrile illnesses in Africa.

Authors:  Martin Wainaina; David Attuy Vey da Silva; Ian Dohoo; Anne Mayer-Scholl; Kristina Roesel; Dirk Hofreuter; Uwe Roesler; Johanna Lindahl; Bernard Bett; Sascha Al Dahouk
Journal:  PLoS Negl Trop Dis       Date:  2022-01-24

5.  High prevalence of Non-typhoid salmonella bacteraemia among febrile HIV adult patients admitted at a tertiary Hospital, North-Western Tanzania.

Authors:  Alfred Meremo; Stephen E Mshana; Benson R Kidenya; Rodrick Kabangila; Robert Peck; Johannes B Kataraihya
Journal:  Int Arch Med       Date:  2012-10-17

6.  Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low- and middle-income countries: a systematic review and meta-analysis.

Authors:  Nina Droz; Yingfen Hsia; Sally Ellis; Angela Dramowski; Mike Sharland; Romain Basmaci
Journal:  Antimicrob Resist Infect Control       Date:  2019-12-30       Impact factor: 4.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.